OTC: PMCUF - Pro Medicus Limited

Rentabilidad a seis meses: +70.42%

Calendario de promoción Pro Medicus Limited

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software.

más detalles
It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

EBITDA 0.0365
EV/EBITDA 72.64
Industry Health Care Technology
P/BV 38.47
P/E 99.14
P/S 37.84
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0714
Див.доход ао 0.4677
Дивиденд ао 0.2466
Сайт https://www.promed.com.au
Цена ао 63.7
Число акций ао 0.10459 млрд
Cambio de precio por semana.: -3.53% (163.775)
Cambio de precio por mes: +5.33% (150)
Cambio de precio en 3 meses.: +31.67% (120)
Cambio de precio en seis meses: +70.42% (92.71)
Cambio de precio por año: +144.02% (64.75)
Cambio de precio en 3 años.: +270.37% (42.66)
Cambio de precio en 5 años.: +1 384.26% (10.645)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 92.7 1
P/BV 53.32 1
P/E 180.83 1
EV/EBITDA 123.33 1
Total: 1

Eficiencia

Nombre Significado Calificación
ROA, % 28.2 8
ROE, % 39.47 9
Total: 9.33

Dividendos

Nombre Significado Calificación
Div yield, % 0.4464 1.13
DSI 0.9286 9.29
Total: 5.24

Deber

Nombre Significado Calificación
Debt/EBITDA 0.025 10
Total: 9.6

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 92.61 9
Rentabilidad Ebitda, % 116.52 10
Rentabilidad EPS, % 142.43 10
Total: 7.8
Más detalles

Dividendo, % Dividendo Con base en los resultados del período. comprar antes Fecha de cierre del registro Pago antes
0.24% 0.15 II кв. 2024 02.09.2024 04.09.2024 19.09.2024
0.19% 0.12 IV кв. 2023 27.02.2024 29.02.2024 15.03.2024
Más detalles

Supervisor Título profesional Pago año de nacimiento
Dr. Sam Aaron Hupert M.B.B.S., M.D. Co-Founder, CEO, MD & Executive Director 724.12k
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. Co-Founder, Technology Director & Executive Director 251.94k
Mr. Clayton James Hatch B.Comm, CPA, CPA Chief Financial Officer 279.15k
Dr. Malte Westerhoff GM of Europe & Global CTO 822.73k
Mr. Brad Levin GM of North America & Global Head of Marketing 261.78k
Ms. Sharni L. Redenbach People & Culture Director N/A
Mr. Sean Lambright Global Head of Sales - Visage Imaging Inc 801.7k
Ms. Teresa Gschwind Global Head of Customer Service of Visage Imaging Inc. N/A
Ms. Danny English C.A. Financial Controller & Company Secretary N/A

DIRECCIÓN: Australia, Richmond. VIC, 450 Swan Street - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.promed.com.au